TGCA
LIVE

Serial Number

88422345

Owner

Therapeutic Genetics Consulting Associates LLC

Attorney

Devon E. White

First Use Date

Apr 12, 2019

Filing Date

May 9, 2019

Add to watchlist:

No watchlists yet
View on USPTO

TGCA Trademark

Serial Number: 88422345 • Registration: 6072598

TGCA is a trademark filed by Therapeutic Genetics Consulting Associates LLC on May 9, 2019. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Therapeutic Genetics Consulting Associates LLC

Suite 315
Chapel Hill, NC 27514

Entity Type: 16

Trademark Details

Filing Date

May 9, 2019

Registration Date

June 9, 2020

First Use Anywhere

April 12, 2019

First Use in Commerce

April 12, 2019

Published for Opposition

March 24, 2020

Goods & Services

Educational services in the field of specialty pharmacy, genetic medicine and therapies, RNA based therapeutics, cell therapies and gene-modified cell therapies, pharmacogenetics, pharmacy payer and reimbursement, therapeutic patient care risk analysis and management, and pharmacy manufacturing, in face-to-face and web-based courses, seminars, workshops and training sessions; Educational services in the field new therapies and risk management for patient care in face-to-face and web-based courses, seminars, workshops and training sessions; Educational services provided to stakeholders, namely, Pharmaceutical Manufacturers, Payers, PBMS, Health Systems, IDN's, Physicians, Specialty Pharmacies, and patients and in the field of genetic therapies and pharmacogenetics in face-to-face and web-based courses, seminars, workshops and training sessions; Providing an educational website portal for providers and patients featuring non-downloadable videos in the field of specialty pharmacies, pharmaceutical manufacturers, genetic medicine and therapies, RNA based therapeutics, cell therapies and gene-modified cell therapies, pharmacy benefit managers, physicians, health systems; Providing an educational website portal for providers and patients featuring non-downloadable videos in the field of new therapies and risk management; Research services, namely, the design and development of data collection methodologies, the collection of data, and the reporting of results for developing training systems and learning methodologies for others

Business management and consultation services in the field of specialty pharmacy, pharmaceutical manufacturers, genetic medicine and therapies, RNA based therapeutics, cell therapies and gene-modified cell therapies, pharmacy benefit managers, physicians, health systems; Business risk management, consulting and information services in the field of specialty pharmacy, pharmaceutical manufacturers, genetic medicine and therapies, RNA based therapeutics, cell therapies and gene-modified cell therapies, pharmacy benefit managers, physicians, health systems; Business marketing consulting services; Business consulting services in the field of pharmaceutical and drug development

Research services, namely, providing customized studies of data and research, namely, medical and scientific research services; Research services, namely, the design and development of data collection methodologies, the collection of data, and the reporting of results for medical research and scientific research purposes; Providing research and support services for the management and reporting of outcomes of therapies, namely, for medical research and scientific research purposes

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 9, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Jun 9, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 24, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 24, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 4, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 18, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 29, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 29, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 29, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 31, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jul 31, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jul 31, 2019 CNRT
ASSIGNED TO EXAMINER
Jul 25, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 23, 2019 NWOS
NEW APPLICATION ENTERED
May 13, 2019 NWAP